Case Studies
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay
TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays ...
Viridian Capital Advisors Reports Valuation Metrics for U.S. MSOs with Market Caps >$100M
LOS ANGELES – Multi-state cannabis operators in the United States are carrying valuation multiples that signal caution among investors, even as growth prospects brighten for the coming year. According to a fresh Weekly Valuation Report ...
OPINION: Industrial hemp just got ‘future proofed.’
NEW YORK- Industrial hemp just received the clearest signal yet that it's not a fad, not a loophole, and not going away. It was effectively declared “future proof.” When Congress passed the funding bill to ...
EU Cannabis Imports Explained: Rules, Regulations, Safety & Quality Control
LOS ANGELES – Germany's medical Cannabis imports reached 56.9 tons in Q3 2025, a 19% jump from the prior period and a fresh record that highlights the market's relentless pull. With an estimated 900k prescriptions ...
Gallup Reveals First Dip in Years for Cannabis Legalization Public Support
LOS ANGELES – A fresh Gallup survey reveals that 64% of American adults now back making Cannabis use legal, a figure that marks the first decline in overall support since 2019 and pulls back from ...
New York Updates Cannabis Packaging, Labeling, and Advertising Regulations
NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to ...
Planet 13 Reports Q3 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening ...
Glass House Brands Reports Q3 2025 Financial Results
LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis ...
Trump Signs Funding Measure Ending Historic 43-Day Government Shutdown, Bans Hemp-Derived THC Products
WASHINGTON – President Donald Trump signed a bipartisan spending package that reopens the federal government after a 43-day impasse, marking the longest such closure in American history. Tucked into the legislation, however, are new limits ...
Opinion: Lean In? Sometimes You Have To Lean Out
LOS ANGELES- For years, women have been told that if we want to succeed, we need to “lean in.” Work twice as hard to get half as much. Push through. Prove ourselves. Be unstoppable. And ...
OPINION: Careful What You Wish For, You Might End Up With A 12-Inch Pianist
LOS ANGELES- The regulated cannabis industry should be collectively objecting to the language in the Big Beautiful Bill that effectively makes intoxicating hemp products illegal in 12 months. They should be screaming from the roof ...
Flower by Edie Parker Teams Up with Verano for Florida Cannabis Debut, Spotlights Rapper JT in Promo Campaign
MIAMI – Flower by Edie Parker, a female-founded, premium Cannabis brand known for its vibrant designs, has struck an exclusive deal with Verano Holdings Corp. to roll out its products across the Sunshine State's medical ...
AbbVie Reveals $900M Upfront Payment in Psychedelic Deal, Signaling Strong Bet on Bretisilocin
CHICAGO – AbbVie Inc. disclosed in a recent securities filing that it handed over $900 million in cash at the outset of its acquisition of bretisilocin, the experimental psychedelic compound acquired from Gilgamesh Pharmaceuticals aimed ...
Rubicon Organics Secures $4M Financing for Facility Upgrades
VANCOUVER, BC – Rubicon Organics Inc. closed a $4 million credit package with Community Savings Credit Union to finance upgrades at its production sites. The deal breaks down into a $3 million term loan carrying ...
The Intoxicating Hemp Ban Is About to Become Law — and It’s a Pyrrhic Victory for Cannabis
LOS ANGELES- The federal government just erased a $20-billion industry under the guise of “closing a loophole.” But rather than protecting consumers, Washington has dealt a crippling blow to both hemp and legal Cannabis — ...
Senate Spending Package Eyes Hemp THC Crackdown as Shutdown Continues, Trump Backs Restrictions
WASHINGTON – A bipartisan spending package drafted to end the nation's longest government shutdown now includes a provision that would sharply curtail sales of hemp-derived THC products, garnering White House endorsement and fierce opposition from ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...
Cronos Group Reports Q3 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some ...
Aurora Cannabis Reports Q2 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. posted a solid second quarter for its fiscal 2026, with total net revenue climbing 11% to CA$90.4 million, driven by a surge in international medical Cannabis sales that highlighted the ...
Cresco Labs Reports Q3 2025 Financial Results
CHICAGO – Cresco Labs, a major player in branded Cannabis products and the Sunnyside retail chain, announced third-quarter results showing revenue of $165 million for the period ended September 30. The figure marked a modest ...
